TCGX Acquisition TCGX

TCGX Acquisition Acquires TriGemX Bio

Item 1.01 Enters material agreement

Form
8-K
Filed
Importance
Major
  1. Business Combination expected to close in Q1 2027
  2. TCGX Acquisition to rebrand as TriGemX Bio, Inc.
  3. Exchange ratio based on $361M pre-money valuation
  4. Shareholders can redeem Class A shares for trust funds

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when TCGX Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (6770) and public float not reported.